Cargando…
A Mixed-Surface Polyamidoamine Dendrimer for In Vitro and In Vivo Delivery of Large Plasmids
Drug delivery to the brain is highly hindered by the presence of the blood–brain barrier (BBB), which prevents the entry of many potential drugs/biomolecules into the brain. One of the current strategies to achieve gene therapy for neurodegenerative diseases involves direct injection of a viral vect...
Autores principales: | Srinageshwar, Bhairavi, Florendo, Maria, Clark, Brittany, Johnson, Kayla, Munro, Nikolas, Peruzzaro, Sarah, Antcliff, Aaron, Andrews, Melissa, Figacz, Alexander, Swanson, Douglas, Dunbar, Gary L., Sharma, Ajit, Rossignol, Julien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407876/ https://www.ncbi.nlm.nih.gov/pubmed/32635142 http://dx.doi.org/10.3390/pharmaceutics12070619 |
Ejemplares similares
-
Use of Polyamidoamine Dendrimers in Brain Diseases
por: Florendo, Maria, et al.
Publicado: (2018) -
PAMAM Dendrimers Cross the Blood–Brain Barrier When Administered through the Carotid Artery in C57BL/6J Mice
por: Srinageshwar, Bhairavi, et al.
Publicado: (2017) -
A novel approach to label bone marrow-derived mesenchymal stem cells with mixed-surface PAMAM dendrimers
por: Munro, Nikolas, et al.
Publicado: (2019) -
PAMAM Dendrimer Nanomolecules Utilized as Drug Delivery Systems for Potential Treatment of Glioblastoma: A Systematic Review
por: Fana, Michael, et al.
Publicado: (2020) -
Current Therapeutic Strategies for Glioblastoma
por: Rossignol, Julien, et al.
Publicado: (2019)